Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02924038
Title A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of California, San Francisco
Indications

malignant astrocytoma

oligodendroglioma

high grade glioma

Therapies

IMA950 + Poly ICLC

Varlilumab

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California San Francisco California 94143 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field